Nonalcoholic fatty liver disease is associated with cognitive function in adults
- PMID: 26911638
- PMCID: PMC4820136
- DOI: 10.1212/WNL.0000000000002498
Nonalcoholic fatty liver disease is associated with cognitive function in adults
Abstract
Objective: We hypothesized that nonalcoholic fatty liver disease (NAFLD) is independently associated with cognitive impairment in a representative sample of the general US population regardless of the presence of cardiovascular disease (CVD) or its risk factors.
Methods: This was a cross-sectional study of 4,472 adults aged 20-59 years who participated in the Third National Health and Nutritional Examination Survey. The participants underwent assessment of liver enzyme activity and hepatic steatosis by ultrasound, and underwent cognitive evaluation using the following computer-administered tests: the Simple Reaction Time Test (SRTT), the Symbol-Digit Substitution Test (SDST), and the Serial Digit Learning Test (SDLT). We defined NAFLD as moderate/severe steatosis as determined by ultrasound in the absence of hepatitis B or C or excessive alcohol consumption. We used multiple linear regression models to examine the association between NAFLD and cognitive function while controlling for potential confounders.
Results: Participants with NAFLD showed lower overall performance on the SDLT (β = 0.726, 95% confidence interval [CI] 0.105-1.347), while associations with SRTT and SDST did not reach significance. Increased activity of the liver enzymes alanine aminotransferase (β = 0.018, 95% CI 0.006-0.030) and aspartate aminotransferase (β = 0.021, 95% CI 0.005-0.037) correlated with lower performance on the SDLT, while increased alanine aminotransferase was also correlated with lower performance in the SDST (β = 0.002, 95% CI 0.0001-0.004).
Conclusions: NAFLD was independently associated with lower cognitive performance independent of CVD and its risk factors. Given the scarcity of risk factors associated with age-related cognitive decline, these findings may have significant implications.
© 2016 American Academy of Neurology.
Figures
Similar articles
-
Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study.Liver Int. 2019 Sep;39(9):1713-1721. doi: 10.1111/liv.14161. Epub 2019 Jun 26. Liver Int. 2019. PMID: 31155826 Free PMC article.
-
Neurobehavioral effects of ambient air pollution on cognitive performance in US adults.Neurotoxicology. 2009 Mar;30(2):231-9. doi: 10.1016/j.neuro.2008.12.011. Epub 2008 Dec 30. Neurotoxicology. 2009. PMID: 19150462
-
A cross sectional study of the association between walnut consumption and cognitive function among adult US populations represented in NHANES.J Nutr Health Aging. 2015 Mar;19(3):284-90. doi: 10.1007/s12603-014-0569-2. J Nutr Health Aging. 2015. PMID: 25732213
-
Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment.J Clin Transl Hepatol. 2022 Dec 28;10(6):1034-1041. doi: 10.14218/JCTH.2021.00490. Epub 2022 Feb 17. J Clin Transl Hepatol. 2022. PMID: 36381086 Free PMC article.
-
Cognitive Function in Individuals with Normal Weight Obesity: Results from the Third National Health and Nutrition Examination Survey (NHANES III).J Alzheimers Dis. 2018;65(1):125-135. doi: 10.3233/JAD-180264. J Alzheimers Dis. 2018. PMID: 30010127
Cited by
-
From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function.Med Sci Monit. 2024 Jan 29;30:e943417. doi: 10.12659/MSM.943417. Med Sci Monit. 2024. PMID: 38282346 Free PMC article. Review.
-
Cognitive impairment and liver fibrosis in non-alcoholic fatty liver disease.BMJ Neurol Open. 2024 Jan 23;6(1):e000543. doi: 10.1136/bmjno-2023-000543. eCollection 2024. BMJ Neurol Open. 2024. PMID: 38268753 Free PMC article.
-
Non-alcoholic fatty liver disease causally affects the brain cortical structure: a Mendelian randomization study.Front Neurosci. 2024 Jan 8;17:1305624. doi: 10.3389/fnins.2023.1305624. eCollection 2023. Front Neurosci. 2024. PMID: 38260009 Free PMC article.
-
Impact of insulin resistance on mild cognitive impairment in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease.Diabetol Metab Syndr. 2023 Nov 10;15(1):229. doi: 10.1186/s13098-023-01211-w. Diabetol Metab Syndr. 2023. PMID: 37950317 Free PMC article.
-
Sex-specific relationship between non-alcoholic fatty liver disease and amyloid-β in cognitively unimpaired individuals.Front Aging Neurosci. 2023 Oct 13;15:1277392. doi: 10.3389/fnagi.2023.1277392. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37901792 Free PMC article.
References
-
- Argo CK, Caldwell SH. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 2009;13:511–531. - PubMed
-
- Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008;28:339–350. - PubMed
-
- Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010;53:372–384. - PubMed
-
- Targher G, Bertolini L, Poli F, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005;54:3541–3546. - PubMed
-
- Stepanova M, Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol 2012;10:646–650. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical